BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/28/2025 6:51:17 AM | Browse: 1 | Download: 0
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Basic Study |
| Article Title |
Melatonin regulates Sirt1/Nrf2/GPX4 pathway to inhibit ferroptosis and alleviate myocardial injury caused by sepsis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Min Zeng, Qiong Li, Lin Li, Cheng-Fang Xiang and Yi-Jun Wang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| 2025 Hunan Provincial Natural Science Foundation Regional Joint Fund |
No. 2025JJ70596 |
|
| Corresponding Author |
Yi-Jun Wang, Research Fellow, Department of Emergency, The First People’s Hospital of Chenzhou, No. 108 Luo Jia Jin Street, Chenzhou 423000, Hunan Province, China. wangyijun202507@163.com |
| Key Words |
Sepsis; Myocardial injury; Echocardiography; Melatonin; Sirtuin 1; Nuclear factor erythroid 2-related factor 2; Glutathione peroxidase 4 |
| Core Tip |
Sepsis often results in myocardial injury, a major cause of death in affected patients. In this study, we demonstrated that melatonin, an endogenous hormone with antioxidant and anti-inflammatory properties, protects against sepsis-induced myocardial injury. Using both a mouse model and HL-1 cardiomyocytes, we found that melatonin improved cardiac function, reduced oxidative stress, and inhibited ferroptosis by activating the Sirt1/Nrf2/GPX4 pathway. These findings provide novel mechanistic insights and highlight the therapeutic potential of melatonin for septic myocardial injury. |
| Citation |
Zeng M, Li Q, Li L, Xiang CF, Wang YJ. Melatonin regulates Sirt1/Nrf2/GPX4 pathway to inhibit ferroptosis and alleviate myocardial injury caused by sepsis. World J Cardiol 2025; In press |
 |
Received |
|
2025-08-25 05:25 |
 |
Peer-Review Started |
|
2025-08-25 05:25 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-09-18 09:26 |
 |
Revised |
|
2025-09-28 08:03 |
 |
Second Decision |
|
2025-11-28 03:01 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-11-28 06:51 |
 |
Articles in Press |
|
2025-11-28 06:51 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345